quantisnow
FeedTopReportsPricing
⌘K
Live feed
20:36:10·759d
INSIDERFiling
Graphite Bio Inc. logo

SEC Form 4 filed by Chevallard Daniel R.

GRPH· Graphite Bio Inc.
Health Care
Original source

Companies

  • GRPH
    Graphite Bio Inc.
    Health Care

Recent analyst ratings

  • Feb 23UpdateBofA Securities$2.00
  • Feb 23UpdateCantor Fitzgerald$3.00
  • Feb 23UpdateCowen-
  • Jan 25UpdateBTIG Research-
  • Jan 18UpdateBofA Securities$3.00
  • Jan 6UpdateSVB Leerink$2.00

Related

  • INSIDER709d
    Mccollum James W bought $501,093 worth of shares (31,332 units at $15.99) (SEC Form 4)
  • SEC714d
    SEC Form 424B3 filed by Graphite Bio Inc.
  • SEC715d
    SEC Form 10-Q filed by Graphite Bio Inc.
  • SEC715d
    Graphite Bio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • SEC743d
    SEC Form EFFECT filed by Graphite Bio Inc.
  • SEC743d
    SEC Form 424B3 filed by Graphite Bio Inc.
  • 13D/G745d
    SEC Form SC 13G/A filed by Graphite Bio Inc. (Amendment)
  • SEC750d
    Graphite Bio Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022